BeOne Medicines (ONC) Tax Provisions (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Tax Provisions of $31.9 million for Q1 2026, up 62.29% year-over-year from $19.6 million in Q1 2025, and down 61.5% quarter-over-quarter from $82.7 million in Q4 2025.
BeOne Medicines (ONC) Tax Provisions (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Tax Provisions for 12 consecutive years, with $31.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions rose 62.29% year-over-year to $31.9 million; the TTM figure through Mar 2026 stood at $142.1 million (up 14.92% YoY), while the FY2025 annual figure was $129.9 million, up 16.22% from the prior year.
- Tax Provisions declined to $31.9 million in Q1 2026 per ONC's latest filing, from $82.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $82.7 million in Q4 2025 and bottomed at $5.2 million in Q2 2025.
- Historically, Tax Provisions has averaged $21.9 million across 5 years, with a median of $14.4 million in 2022.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 3639.57% — and 2025, when it plunged 63.9%.
- BeOne Medicines' Tax Provisions stood at $14.4 million in 2022, then increased by 16.78% to $16.8 million in 2023, then surged by 296.46% to $66.5 million in 2024, then increased by 24.36% to $82.7 million in 2025, then slumped by 61.5% to $31.9 million in 2026.
- Business Quant data shows ONC's Tax Provisions at $31.9 million in Q1 2026, $82.7 million in Q4 2025, and $22.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.45 Mn |
| Mar 31, 2026 | 31.86 Mn |
| Dec 31, 2025 | 82.74 Mn |
| Sep 30, 2025 | 22.32 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | 19.63 Mn |
| Dec 31, 2024 | 66.53 Mn |
| Sep 30, 2024 | 23.05 Mn |
| Jun 30, 2024 | 14.49 Mn |
| Mar 31, 2024 | 7.72 Mn |
| Dec 31, 2023 | 16.78 Mn |
| Sep 30, 2023 | 13.93 Mn |
| Jun 30, 2023 | 13.67 Mn |
| Mar 31, 2023 | 11.49 Mn |
| Dec 31, 2022 | 14.37 Mn |
| Sep 30, 2022 | 6.32 Mn |
| Jun 30, 2022 | 8.14 Mn |
| Mar 31, 2022 | 13.95 Mn |
| Dec 31, 2021 | -15.35 Mn |
| Sep 30, 2021 | 5.04 Mn |